SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Themis Medicare gains on incorporating JV Company ‘Carpo Medical’ in UK

19 Apr 2017 Evaluate

Themis Medicare is currently trading at Rs. 605.05, up by 3.30 points or 0.55% from its previous closing of Rs. 601.75 on the BSE.

The scrip opened at Rs. 610.00 and has touched a high and low of Rs. 610.00 and Rs. 605.00 respectively. So far 255 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 708.95 on 28-Oct-2016 and a 52 week low of Rs. 395.00 on 28-Apr-2016.

Last one week high and low of the scrip stood at Rs. 630.00 and Rs. 576.60 respectively. The current market cap of the company is Rs. 551.41 crore.

The promoters holding in the company stood at 67.05%, while institutions and non-institutions held 0.01% and 32.94% respectively.

Themis Medicare has incorporated a joint venture (JV) company in United Kingdom known as Carpo Medical as a Private Limited Company. The company holds 90% of the share capital and Well Medical (JV partner based in UK) holds 10% of the share capital in the aforesaid joint venture company.

Themis Medicare is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs) and Formulations. The company is also engaged in supplying their research formulations to well-known Pharmaceutical companies in India namely Alkem Lab, Fulford, Intas Pharmaceuticals, IPCA Lab., Cadila Healthcare, Aristo Pharma, Mankind Pharma, Shreya Lifesciences, Nicholas Piramal, Unichem Lab, etc.

Themis Medicare Share Price

90.25 4.97 (5.83%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×